Leaderboards/Pancreatic and Hepatic Oncology Research

Pancreatic and Hepatic Oncology Research

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Jeffrey S. Barrett
Aridhia (United Kingdom)
99
2
Saxon Connor
Christchurch Hospital
54
3
Jing Guo
Beijing Biocytogen (China)
50
4
Hai‐Dong Zhu
Southeast University
50
5
И. С. Стилиди
Ministry of Health of the Russian Federation
50
6
Mirko D’Onofrio
Unknown
50
7
Yen‐Kuang Lin
National Taiwan Sport University
50
8
Ken Kato
Tokyo National Hospital
50
9
S.A. Jonah
National Institute of Ayurveda
50
10
Wenlin Tai
Kunming Medical University
40

Rising Stars Papers

1
Lipoprotein(a)/CD36 Interaction Drives IL-6/RhoA-GTP Signaling and miRNA Epigenetic Regulation in Coronary Artery Spasm
Pharmaceuticals|2025
1 cit.
2
Lipoprotein(a) Triggers CD36-Dependent IL-6/RhoA-GTP Axis Activation and Epigenetic Regulation of miRNA Expression in Coronary Artery Spasm
Preprints.org|2025
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Zhi Zheng
National Clinical Research Center for Digestive Diseases
99
2
Jay Zhang
Beijing Biocytogen (China)
50
3
S. Jan
Unknown
50
4
Jasmine H. Francis
Memorial Sloan Kettering Cancer Center
50
5
Muhammad Akbar
Unknown
50
6
Mi Young
Genome Research Foundation
50
7
Flavio Spoto
Ospedale Sacro Cuore Don Calabria
50
8
М. G. Abgaryan
Ministry of Health of the Russian Federation
50
9
Runlin Feng
Kunming Medical University
40

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Christopher L. Wolfgang
Johns Hopkins University
99
2
Dirk Arnold
Asklepios Klinik Altona
99
3
Fausto Roila
Santa Maria Nuova Hospital
76
4
Ayşe Ocak Duran
Ankara Onkoloji Eğitim ve Araştırma Hastanesi
66
5
Jeffrey S. Barrett
Aridhia (United Kingdom)
63
6
Jacques De Grève
Mathys (Netherlands)
62
7
Florian Lordick
Unknown
60
8
Zhongtao Zhang
Capital Medical University
56
9
Saxon Connor
Christchurch Hospital
56
10
K K Koticha
CHRISTUS Highland Medical Center
55

All-Time Leaders Papers

1
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
Annals of Oncology|2012
854 cit.
2
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology|2017
829 cit.
3
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells
PLoS ONE|2013
267 cit.
4
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab
BMC Medicine|2012
131 cit.
5
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib
Oncotarget|2016
100 cit.
6
TNF-α promotes colon cancer cell migration and invasion by upregulating TROP-2
Oncology Letters|2018
87 cit.
7
Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
PLoS ONE|2013
51 cit.
8
Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells
Biological Procedures Online|2010
46 cit.
9
Type II RAF inhibitor causes superior ERK pathway suppression compared to type I RAF inhibitor in cells expressing different BRAF mutant types recurrently found in lung cancer
Oncotarget|2018
31 cit.
10
Identification of a novel HER3 activating mutation homologous to EGFR-L858R in lung cancer
Oncotarget|2015
22 cit.

Reagents for Pancreatic and Hepatic Oncology Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Miltenyi Biotec

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, PE

Cited in 17 papers
#130-136-356
View Evidence →Miltenyi Biotec

MHC MACSimer A*0201 KRAS-G12V (KLVVVGAVGV), human, Vio667

Cited in 17 papers
#130-135-297
View Evidence →Santa Cruz Biotechnology

KRAS Antibody (B-12)

Cited in 17 papers
#sc-518124
View Evidence →

🌟 All-Time

Most validated

Novus

KRAS Antibody (OTI2C1) [DyLight 350]

Cited in 21 papers
#NBP2-71079UV
View Evidence →Novus

KRAS Antibody (OTI2C1) [DyLight 405]

Cited in 21 papers
#NBP2-71079V
View Evidence →Cell Signaling Technology

GRB7 (E3W4G) Rabbit Monoclonal Antibody

Cited in 20 papers
#76518$161
View Evidence →